AU2003249272A1 - Enhanced phospholipid reduction and calcification mitigation of biological materials - Google Patents

Enhanced phospholipid reduction and calcification mitigation of biological materials

Info

Publication number
AU2003249272A1
AU2003249272A1 AU2003249272A AU2003249272A AU2003249272A1 AU 2003249272 A1 AU2003249272 A1 AU 2003249272A1 AU 2003249272 A AU2003249272 A AU 2003249272A AU 2003249272 A AU2003249272 A AU 2003249272A AU 2003249272 A1 AU2003249272 A1 AU 2003249272A1
Authority
AU
Australia
Prior art keywords
biological materials
enhanced phospholipid
calcification mitigation
reduction
phospholipid reduction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003249272A
Inventor
Crystal Cunanan
Than T. Dinh
Sophia Rubalcaba
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edwards Lifesciences Corp
Original Assignee
Edwards Lifesciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edwards Lifesciences Corp filed Critical Edwards Lifesciences Corp
Publication of AU2003249272A1 publication Critical patent/AU2003249272A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/505—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/143—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/02—Treatment of implants to prevent calcification or mineralisation in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2003249272A 2002-07-16 2003-07-16 Enhanced phospholipid reduction and calcification mitigation of biological materials Abandoned AU2003249272A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39687902P 2002-07-16 2002-07-16
US60/396,879 2002-07-16
PCT/US2003/022121 WO2004006974A1 (en) 2002-07-16 2003-07-16 Enhanced phospholipid reduction and calcification mitigation of biological materials

Publications (1)

Publication Number Publication Date
AU2003249272A1 true AU2003249272A1 (en) 2004-02-02

Family

ID=30116063

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003249272A Abandoned AU2003249272A1 (en) 2002-07-16 2003-07-16 Enhanced phospholipid reduction and calcification mitigation of biological materials

Country Status (7)

Country Link
US (1) US20040093674A1 (en)
EP (1) EP1531878A1 (en)
JP (1) JP2005532877A (en)
AU (1) AU2003249272A1 (en)
BR (1) BR0305562A (en)
CA (1) CA2490060A1 (en)
WO (1) WO2004006974A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7955788B2 (en) * 2003-10-30 2011-06-07 Medtronic, Inc. Bioprosthetic tissue preparation with synthetic hydrogels
US7422607B2 (en) * 2004-08-24 2008-09-09 Oviatt Henry W Anti-calcification treatments for heart valves and vascular grafts
US20060110370A1 (en) * 2004-11-23 2006-05-25 Pathak Chandrashenkhar P Treatments for reduction of cytotoxicity and viral contamination of implantable medical devices
US7989157B2 (en) * 2005-01-11 2011-08-02 Medtronic, Inc. Solution for storing bioprosthetic tissue used in a biological prosthesis
FR2951549B1 (en) * 2009-10-15 2013-08-23 Olivier Schussler PROCESS FOR OBTAINING IMPLANTABLE MEDICAL BIOPROTHESES
US9095430B2 (en) 2010-08-24 2015-08-04 Southern Lights Ventures (2002) Limited Biomaterials with enhanced properties and devices made therefrom
WO2020208644A1 (en) * 2019-04-10 2020-10-15 Meril Life Sciences Pvt. Ltd. A process for prevention of degradation and degeneration of tissue used in bioprosthesis
CN110339400A (en) * 2019-08-07 2019-10-18 太仓新亚逊生物科技有限公司 The anticalcium processing method of biomaterial
CN117899269A (en) * 2022-10-12 2024-04-19 上海微创心通医疗科技有限公司 Anti-calcification method of bioprosthetic tissue and bioprosthetic tissue

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3379568D1 (en) * 1982-11-12 1989-05-18 Baxter Int Surfactant treatment of implantable biological tissue to inhibit calcification
JPS59502104A (en) * 1982-11-12 1984-12-20 バスクー　インターナショナル　インコーポレーテッド Treatment with surfactants to inhibit calcium deposition in transplantable biological tissues
CA2046592C (en) * 1989-02-17 2000-05-02 Aws Nashef Calcification mitigation of bioprosthetic implants
JPH04288165A (en) * 1991-03-18 1992-10-13 Terumo Corp Organ implant and manufacture thereof
US5931969A (en) * 1994-07-29 1999-08-03 Baxter International Inc. Methods and apparatuses for treating biological tissue to mitigate calcification
US6214054B1 (en) * 1998-09-21 2001-04-10 Edwards Lifesciences Corporation Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
US20020137024A1 (en) * 2000-11-01 2002-09-26 Cunanan Crystal M. Methods for preparation of bioprosthetic tissue and implantable devices comprising such bioprosthetic tissue
US20030050276A1 (en) * 2001-08-15 2003-03-13 Cunanan Crystal M. Treatment of tissue, instruments and work surfaces to remove infectious agents

Also Published As

Publication number Publication date
JP2005532877A (en) 2005-11-04
EP1531878A1 (en) 2005-05-25
WO2004006974A1 (en) 2004-01-22
US20040093674A1 (en) 2004-05-20
CA2490060A1 (en) 2004-01-22
BR0305562A (en) 2004-09-28

Similar Documents

Publication Publication Date Title
AU2003286612A1 (en) Satiation implants and methods of use
AU2003217870A1 (en) Pini-modulating compounds and methods of use thereof
AU2003225668A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003239957A1 (en) Optically-connected implants and related systems and methods of use
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
AU2003213673A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003256654A1 (en) Hydrophobic surface treatment composition and method of making and using same
AU2003277597A1 (en) Cleaning composition and method of cleaning therewith
AUPS200702A0 (en) Treatment of hazardous waste material
AU2003299478A1 (en) Bioactivation of particles
AU2003249272A1 (en) Enhanced phospholipid reduction and calcification mitigation of biological materials
AU2003278929A1 (en) Treatment of pancreatitis with amylin
AU2003229437A1 (en) Use of lanthanum for the treatment of hypercalcemia and bone metastasis
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2003285686A1 (en) Glycoisoforms of adiponectin and uses thereof
AU2003295107A1 (en) Biological control agent and formulations
AU2003282593A1 (en) Polyphenolamine composition and method of use
AU2003298441A1 (en) Biological control agent and formulations
AU2003260316A1 (en) Regulation of human hepsin
AU2003259689A1 (en) 3-imino-2-indolones for the treatment of depression and/or anxiety
AU2003277537A1 (en) REGULATION OF INTERACTION BETWEEN RAPL AND Rap1
AU2003274359A1 (en) Treatment of fluids
AU2003266271A1 (en) Regulation of human esterase
AU2003255635A1 (en) Simple and multiple emulsions for decontamination of an organism or surfaces
AU2003296356A1 (en) Determination of dose-enhancing agent concentration and dose enhancement ratio

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase